Substance Abuse, Addiction & Deterrence

Mandatory opioid tapers could sometimes do more harm than good, international medical experts warn in an open letter to health authorities.


Higher national average cannabis potency at first cannabis use is associated with an increased risk of progression to symptomatic cannabis use, according to new findings.

More than two in five teens who use marijuana experience psychotic symptoms like hallucinations, paranoia and anxiety, a U.S. study suggests.

As the opioid epidemic deepens, a government-backed panel that routinely draws up guidelines for disease prevention is starting to search for ways to prevent addiction to these drugs in the first place.

Indivior Plc said on Tuesday it could launch a cheaper version of its blockbuster opioid addiction treatment, Suboxone, if rivals release generic versions of the drug.

Buprenorphine-naloxone should be favored over extended-release naltrexone as first-line treatment for opioid use disorder (OUD) in adults, according to a cost-effectiveness analysis.



I have a common kind of patient in my practice—he is somewhere in his late teens or early twenties, usually living at home, maybe taking a class or two at the community college, more often working but certainly not able to support himself without the help of his parents. His hobbies are often solitary, like video games. And he’s using a lot of cannabis.

When Robin Williams committed suicide this week, he shocked a nation who had delighted for years in the bright light of his rapid-fire, witty humor. How should we as mental health professionals respond to such a public suicide?

If your clinical practice is like mine, you’re seeing more patients who are using cannabis, or are more willing to admit to using the drug. Here are three tips to keep you up to date.



Bernd Wollschlaeger, MD, FAAFP, FASAM; Leslie Montejano, MA, CCRP; Tina Willson, PhD; Naoko Ronquest, PhD; Vijay Nadipelli, BPharm, MS
Patrick Lefebvre, MA; Erik Muser, PharmD, MPH; Kruti Joshi, MPH; Maral DerSarkissian, PhD; Rachel Bhak, MS; Mei Duh, ScD, MPH; Brian Shiner, MD, MPH; Yinong Young-Xu, ScD, MS, MA
Thien-Huong Vu, MD, Rocha Evita, MD, Andrei Novac, MD, Regina Groysman, MD
Lynn Mainolfi, DNP, PMHNP-BC, Thomas Cline, MBA, PhD, Judith Kaufmann, Dr.PH, CRNP, Janene Szpak, DNP, PMHNP-BC



Andrew Penn, RN, MS, CNS, NP, PMHNP-BC and Charles Raison, MD discuss how cannabis can affect mental health.

Charles Raison, MD and Andrew Penn, RN, MS, CNS, NP, PMHNP-BC discuss how cannabis use delays emotional maturity.

Andrew Penn, RN, MS, NP, CNS, APRN-BC: I'm very wary of certain groups of patients using cannabis. It's important for clinicians to identify these patients and help them find alternatives to cannabis use.